ActoGeniX: Intrexon Prices Public Offering Of Common Stock

GERMANTOWN, Md., Aug. 21, 2015 /PRNewswire/ --Intrexon Corporation (NYSE: XON), a leader in synthetic biology, announced today that it has priced its previously announced underwritten public offering of common stock consisting of4,878,049 shares at a public offering price of $41.00